Tojsiab
Lub Chaw Tswj Xyuas Khoom Noj thiab Tshuaj rau hnub Monday poob siab tso cai a pheej yig thiab dav muaj antidepressant raws li kev kho mob rau Covid-19, pom tias a txoj kev tshawb no qhia tau hais tias cov tshuaj tau zoo tiv thaiv tus kab mob no hnyav heev txwv.
Cov ntaub ntawv ua ntej qhia tau hais tias cov tshuaj tiv thaiv kev ntxhov siab fluvoxamine tuaj yeem tiv thaiv tau … [+]
txais
Cov Lus Tseem Ceeb
Fluvoxamine txiv neej- uas yog siv los kho kev nyuaj siab, obsessive-compulsive tsis meej thiab lwm yam mob - kuj muaj cov tshuaj tiv thaiv kab mob, ua rau nws kho tau rau Covid-19, uas pom tau tias ua rau muaj ntau yam ntawm nws cov tsos mob los ntawm o.
Qhov kev thov rau FDA kev tso cai siv thaum muaj xwm txheej ceev rau fluvoxamine tau ua raws li qhov tseem ceeb ntawm a kev kawm ua ntej luam tawm nyob rau hauv Lub ib hlis ntuj los ntawm lub Lancet, uas qhia tau hais tias cov tshuaj txo cov kev pheej hmoo ntawm kev mus pw hauv tsev kho mob lossis kev saib xyuas xwm txheej ceev rau XNUMX teev los ntawm 32% ntawm cov neeg mob uas muaj kev pheej hmoo siab ntawm Covid-19 hnyav.
Txawm li cas los xij, hauv a tsawg daim ntawv qhia Hnub Monday piav txog nws qhov kev txiav txim siab tsis lees txais daim ntawv thov, FDA tau hais tias txoj kev tshawb fawb muaj kev txwv tsis pub tsim, suav nrog cov qauv me me thiab tsis muaj qhov sib txawv, ua rau nws tsis txaus siab raws li qhov xwm txheej rau fluvoxamine qhov txiaj ntsig tiv thaiv Covid-19.
FDA kuj nug Cov kws tshawb fawb qhov kev txiav txim siab los ntsuas kev saib xyuas xwm txheej ceev ntawm rau teev lossis ntev dua, thiab hais tias rau teev yuav tsis yog qhov chaw kho mob tseem ceeb.
ob tug lwm yam cov kev tshawb fawb, ib qho ntawm cov loj tshaj qhov Lancet txoj kev tshawb no, ua tsis tau tejyam qhia tias fluvoxamine tau zoo rau cov neeg laus uas mob me Covid-19, FDA tau taw qhia.
Daim ntawv thov kev tso cai siv thaum muaj xwm ceev rau fluvoxamine tau ua rau lub Kaum Ob Hlis 21 los ntawm Dr. David Boulware, University of Minnesota tus kws kho mob tshwj xeeb.
Contra
Txawm hais tias fluvoxamine tseem tsis tau muaj pov thawj zoo tiv thaiv Covid-19, FDA tau xaus lus, qee cov kws tshawb fawb tau hais tias qhov ua ntej Lancet kawm warrants tshawb nrhiav ntxiv. Cov tshuaj no muaj kev txaus siab tshwj xeeb vim tias nws tuaj yeem siv los kho Covid-19 thaum ntxov ntawm kev kis tus kab mob raws li lwm txoj hauv kev pheej yig thiab nyuaj-tau. Kev kho mob monoclonal antibody, Scripps Research Translational Institute Director Dr. Eric Topol hais rau LUB ROOB.
Tus Keeb Kwm Tseem Ceeb
Fluvoxamine, ua lag luam raws li lub npe Luvox, yog pom zoo los kho tej yam mob xws li kev nyuaj siab thiab obsessive-compulsive disorder nyob rau hauv 2007. Txij thaum ntawd los, nws tau dhau los ua thoob plaws hauv Tebchaws Meskas txog li. $4 rau kev kawm 10 hnub. Kev sim thawj zaug hauv xyoo 2021 qhia tias fluvoxamine tuaj yeem ua tau zoo tawm tsam Covid-19, txhawb kev txaus siab rau cov tshuaj. Txawm li cas los xij, cov kev sim tom ntej tau ua rau cov txiaj ntsig tsis sib xws, thiab muaj pov thawj qhov ncauj Covid-19 tshuaj tiv thaiv zoo li Pfizer's Paxlovid tau tshwm sim ntawm kev ua lag luam txij thaum ntawd los. Thawj Tswj Hwm Biden tau xaj 20 lab cov kev kawm ntawm Paxlovid, thiab tshaj tawm txoj kev npaj ua kom cov tshuaj muaj nyob rau ntawm cov khw muag tshuaj thoob plaws Tebchaws Meskas.
ntxiv nyeem ntawv
"Rau Txoj Kev Fluvoxamine tuaj yeem ua los tiv thaiv Covid-19 hnyav" (Forbes)
Tau qhov twg los: https://www.forbes.com/sites/zacharysmith/2022/05/16/fda-rejects-bid-to-authorize-cheap-antidepressant-as-covid-treatment/